Topic

New York

A collection of 443 issues

Getting Ilaris (Canakinumab) Covered by UnitedHealthcare in New York: Complete Prior Authorization and Appeal Guide

Answer Box: Quick Path to Ilaris Coverage in New York UnitedHealthcare requires prior authorization for Ilaris (canakinumab) in New York. Submit through a rheumatologist or immunologist with complete diagnostic documentation, lab results showing inflammation (elevated CRP, ESR, ferritin), and evidence of failed first-line therapies. If denied, you have 180 days
6 min read

How to Get Vimizim (Elosulfase Alfa) Covered by Humana in New York: Requirements, Appeals, and Timeline

Answer Box: Getting Vimizim Covered by Humana in New York Who qualifies: Patients with confirmed MPS IVA (Morquio A syndrome) diagnosis through enzyme testing and genetic confirmation. Fastest approval path: Submit prior authorization with specialist attestation, diagnostic test results, and baseline functional measures. Start today: Contact your prescribing specialist to
6 min read

Crysvita (Burosumab) Approval with UnitedHealthcare in New York: Complete Guide to Prior Authorization, Appeals, and Coverage

Answer Box: Getting Crysvita Covered by UnitedHealthcare in New York UnitedHealthcare covers Crysvita (burosumab) for X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia (TIO) with prior authorization in New York. Key requirements include confirmed diagnosis via genetic testing or elevated FGF23, specialist prescribing, and documented clinical need. First step today: Contact your
6 min read

How to Get Mycapssa (Octreotide Oral) Covered by Aetna CVS Health in New York: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Mycapssa Covered by Aetna CVS Health in New York Eligibility: Mycapssa (octreotide oral) requires prior authorization from Aetna CVS Health for acromegaly patients who previously responded to injectable octreotide or lanreotide. Fastest path: Have your endocrinologist submit a PA request through the Availity provider portal with documented
6 min read

How Long Does It Take to Get Vyndaqel / Vyndamax (tafamidis) Approved by Humana in New York? Complete Timeline Guide

Quick Answer: Vyndaqel / Vyndamax Approval Timeline with Humana Standard approval: 30 days from complete submission. Expedited review: 72 hours if medically urgent. Key requirements: Confirmed ATTR-CM diagnosis (PYP scan or biopsy), NYHA Class I-III, cardiology oversight. Fastest path: Submit complete PA packet with diagnostic imaging, specialist letter, and prior therapy
5 min read